Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 9,540 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: HEARTS Clear all

Conditions: Cardiovascular Disease, Cerebrovascular Accident, Coronary Heart Disease
Interventions: Atorvastatin; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 35 Years to 75 Years
Enrollment: 8,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2004
U.S. locations: 181
States / cities: Alabaster, Alabama • Birmingham, Alabama • Hoover, Alabama + 129 more

Conditions: Dietary Modification
Interventions: Tart cherry Juice, High-fat meal, Exercise; Dietary Supplement · Other
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Anxiety, Memory, Epilepsy
Interventions: CAMERA (Context-Aware Multimodal Ecological Research and Assessment); Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Heart Failure
Interventions: Simvastatin; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 85 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Childhood Obesity
Interventions: Newsletters, Family-based Telehealth Intervention; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 5 Years to 11 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Congestive Heart Failure, Coronary Artery Disease, Myocardial Infarction
Interventions: MyoCell™ Autologous Myoblasts; Drug
Lead sponsor: Bioheart, Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 5
States / cities: Fort Lauderdale, Florida • Atlanta, Georgia • Chicago, Illinois + 2 more

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years to 79 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Heart Failure, Systemic Inflammation
Interventions: Ziltivekimab, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 673 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 37
States / cities: Alexander City, Alabama • Fairhope, Alabama • Little Rock, Arkansas + 33 more

Conditions: Chronic Pediatric Heart Failure
Interventions: CRT device implant; Device
Lead sponsor: University of Utah; Other
Eligibility: 1 Year to 18 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Atrial Fibrillation, Persistent Atrial Fibrillation
Interventions: CardioInsight ECGI Mapping System, AF ablation, Ibutilide; Device · Procedure · Drug
Lead sponsor: Vivek Reddy; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiac Failure, Congestive Heart Failure
Interventions: Heart Failure Disease Management Program, Heart Failure Usual Care; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: Not listed
Enrollment: 713 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Automated Measurement of Vital Signs
Interventions: Vital Signs Patch (VSP) System 3-Lead (NEHB) Configuration, Vital Signs Patch (VSP) System 1-Lead (PAL) Configuration; Device
Lead sponsor: LifeWatch Services, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Physical Activity
Interventions: Physical Activity Promotion Intervention; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Lincoln, Nebraska

Conditions: Diffuse Large B-cell Lymphoma
Interventions: Loncastuximab Tesirine, Rituximab; Drug
Lead sponsor: ADC Therapeutics S.A.; Industry
Eligibility: 65 Years and older
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 29
States / cities: Tucson, Arizona • Little Rock, Arkansas • Aurora, Colorado + 24 more

Conditions: COPD
Interventions: Esophageal and gastric balloons, Respiratory Inductance Plethysmography (RIP) system, Sentec transcutaneous monitoring system, High-flow humidified nasal oxygen delivery system, CPAP (Positive Control); Other · Device
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atrial Fibrillation
Interventions: Drug (Direct thrombin or Factor Xa inhibitor); Other
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 10
States / cities: Los Angeles, California • Chicago, Illinois • Boston, Massachusetts + 6 more

Conditions: Coronary Microvascular Dysfunction
Interventions: Polyphenol-Rich Plant-Based Diet; Other
Lead sponsor: Emory University; Other
Eligibility: 45 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Cardiac Surgical Procedures
Interventions: Multi-modal Opioid Sparing Pain Management Protocol; Other
Lead sponsor: Prisma Health-Upstate; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Heart Failure
Interventions: Spironolactone; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Spinal Cord Injury, Tetraplegia
Interventions: Circuit Resistance Training (CRT); Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Fetal Atrial Flutter Without Hydrops, Fetal Supraventricular Tachycardia Without Hydrops, Fetal Supraventricular Tachycardia With Hydrops
Interventions: Digoxin (monotherapy), Sotalol (monotherapy), Flecainide (monotherapy), Digoxin (dual therapy), Sotalol (dual therapy), Flecainide (dual therapy); Drug
Lead sponsor: Edgar Jaeggi; Other
Eligibility: 16 Years to 50 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 12
States / cities: San Francisco, California • Aurora, Colorado • Washington D.C., District of Columbia + 8 more

Conditions: Congenital Heart Disease, Single-ventricle
Interventions: Transthoracic Echocardiogram or Cardiac MRI, Ventripoint Echocardiogram; Device
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Systolic Heart Failure
Interventions: Not listed
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Post Concussion Syndrome
Interventions: Graduated exercise protocol; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 13 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Search by objective public record fields.

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

Antioxidant Responses to Exercise and Cherry Consumption

Prediction of Anxiety and Memory State

The Effect of Simvastatin Therapy on the Expression of Procoagulant and Inflammatory Markers in Heart Failure

A Theory Driven, Rurally Tailored, Family-Based, Telehealth Intervention for Childhood Obesity

Autologous Cultured Myoblasts (BioWhittaker) Transplanted Via Myocardial Injection

Organization in Acute Atrial Fibrillation Post Open Heart Surgery

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

CRT Pilot Study for Children With Heart Failure

ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization

Heart Failure Management Program Versus Usual Care

Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting

Physical Activity Telehealth Intervention After Percutaneous Coronary Procedures

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Pilot Study of Physiological Effect of High-Flow Nasal Cannula on Respiratory Pattern and Work of Breathing

Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial Fibrillation

A Plant-Based Diet in the Treatment of Coronary Microvascular Dysfunction

Opioid Sparing Pain Management Strategy

Novel Treatment for Diastolic Heart Failure in Women

Effects of Exercise in People With Tetraplegia

Prospective Randomized Clinical Trial of Fetal Atrial Flutter & Supraventricular Tachycardia Therapy (FAST RCT)

Ventripoint Single Ventricle Study

Pilot Study Using Echocardiography to Evaluate Patients With Heart Failure and Dyssynchrony Who Have a CRT-D Device

Assessing the Effects of a Clinical Exercise Protocol on Children With Post-concussion Syndrome